Journal article
A phase I–II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798)
Authors
Knox JJ; Chen XE; Feld R; Nematollahi M; Cheiken R; Pond G; Zwiebel JA; Gill S; Moore M
Journal
Investigational New Drugs, Vol. 26, No. 2, pp. 193–194
Publisher
Springer Nature
Publication Date
April 1, 2008
DOI
10.1007/s10637-007-9104-1
ISSN
0167-6997